Phathom Pharmaceuticals, Inc.PHATNASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
60.46%
↑ 126% above average
Average (30q)
-233.62%
Historical baseline
Range
High:79.45%
Low:-6915.35%
Volatility
-2994.0%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 60.46% |
| Q2 2025 | 19.62% |
| Q1 2025 | -26.68% |
| Q4 2024 | 13.00% |
| Q3 2024 | 6.42% |
| Q2 2024 | -10.37% |
| Q1 2024 | -4.13% |
| Q4 2023 | -84.00% |
| Q3 2023 | -5.56% |
| Q2 2023 | -8.33% |
| Q1 2023 | 31.31% |
| Q4 2022 | -7.74% |
| Q3 2022 | -0.34% |
| Q2 2022 | -25.22% |
| Q1 2022 | -13.51% |
| Q4 2021 | 2.28% |
| Q3 2021 | -0.30% |
| Q2 2021 | -4.90% |
| Q1 2021 | 35.14% |
| Q4 2020 | -57.52% |
| Q3 2020 | -61.63% |
| Q2 2020 | -4.77% |
| Q1 2020 | 79.45% |
| Q4 2019 | -43.89% |
| Q3 2019 | 22.39% |
| Q2 2019 | -6915.35% |
| Q1 2019 | -158.47% |
| Q4 2018 | -66.90% |
| Q3 2018 | -12.84% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |